Background:
Hepatocellular carcinoma (HCC) is a common type of cancer with a high
mortality rate and is usually detected at the middle or late stage, missing the optimal treatment period.
The current study aims to identify potential long non-coding RNA (lncRNAs) biomarkers that
contribute to the diagnosis and prognosis of HCC.
Methods:
The differentially expressed lncRNAs (DElncRNAs) in HCC patientsThe differentially expressed lncRNAs (DElncRNAs) in HCC patients were detected
from the Cancer Genome Atlas (TCGA) dataset. LncRNAs signature was screened by LASSO regression,
univariate, and mul...
